Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami ...Middle East

NEW YORK, Dec. 27, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it has received approval from the University of Miami to enroll patients for its first in human clinical trial of HT-001. This First-in-Human...

Hence then, the article about hoth therapeutics announces expansion of fda cleared first in human clinical trial for cancer patients of ht 001 at university of miami was published today ( Wednesday 27/12/2023 - 04:29 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami )

Also on site :

• Not to be dramatic, but LEGO Batman: Legacy of the Dark Knight might be the best Batman game ever
• UN welcomes ceasefire announced by Ukraine, Russia
• US greenlights bomb deal for Ukraine